DateTime Object ( [date] => 2022-08-18 10:55:11.340202 [timezone_type] => 3 [timezone] => UTC )
  • Novel Non-stimulant ADHD Treatments: A Review for Pharmacists | PTCE Pharmacy Connect

    Educational Objectives

    • Describe the impact of ADHD and new non-stimulant class of ADHD treatments
    • Highlight the role of the pharmacist in patient counseling, monitoring and medication management in ADHD


    Faculty:

    Sandy Mullen, PharmD, BCPP

    Clinical Pharmacy Specialist - Child and Adolescent Psychiatry 

    Department of Pharmacy 

    Virginia Commonwealth University (VCU) Health

    Richmond, VA


    Sandy Mullen, PharmD, BCPP, has no financial relationships with commercial interests to disclose.


    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-22-127-H01-P. The activity is available for CE credit through March 30, 2023.


    This activity is supported by an educational grant from Supernus.

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    DateTime Object ( [date] => 2022-08-18 10:55:12.974466 [timezone_type] => 3 [timezone] => UTC )
    Array ( [id] => 5bbd0f66-0f64-11ed-b62c-2b0bc248cb3c [createdAt] => 2022-07-29T19:32:02.760+02:00 [updatedAt] => 2022-07-29T19:50:38.917+02:00 [title] => Use of Novel Therapies in Endometrial Cancer: Update for Managed Care | PTCE Pharmacy Connect [pubdate] => 2022-07-29T19:32:01.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/5bbd0f66-0f64-11ed-b62c-2b0bc248cb3c/image/PTCE.jpeg?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Accreditation and support statement:

    ·   PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.

    ·   This activity is supported by educational grant from GlaxoSmithKline.

    Objectives

    •   Review the guideline-recommended role of immune-based therapies in the management of endometrial cancer.

    •   Discuss access to care, cost of care and cost-effectiveness of Immune checkpoint inhibitors in the treatment of endometrial cancer.

     

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/5bbd0f66-0f64-11ed-b62c-2b0bc248cb3c/stripped_fb873056825af84edd296bbc18e2514c.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN7720098033.mp3 [size] => 60242964 [duration] => 1882.59 [uid] => CSN7720098033 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/5bbd0f66-0f64-11ed-b62c-2b0bc248cb3c/id3/9882e7cabc73e83e4c30a07fc5821003.mp3 [id3FileProcessing] => [id3FileSize] => 301836 [parentId] => [guid] => [pubdateTimezone] => [originalFilename] => Endo Cancer 2 | PTCE.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-07-29T19:33:41.578+02:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Accreditation and support statement:·   PTCE is accredited by the...
  • Array ( [id] => e448bcb0-0f62-11ed-aa88-07fe75d945cd [createdAt] => 2022-07-29T19:21:32.827+02:00 [updatedAt] => 2022-07-29T19:40:52.135+02:00 [title] => HIV Preexposure Prophylaxis (PrEP): Exploring the Current and Emerging Landscape | PTCE Pharmacy Connect [pubdate] => 2022-07-29T19:20:13.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/e448bcb0-0f62-11ed-aa88-07fe75d945cd/image/PTCE.jpeg?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

     Educational Objectives

    ·      Discuss currently available options for pre-exposure prophylaxis (PrEP) in the prevention of HIV.

    ·      Describe the role of pharmacists in improving PrEP uptake in the United States. 

     

     

    Faculty:

    Drew W. Cates, PharmD, AAHIVP,

    Educational Manager

    SynerGrx

    Chamblee, Georgia 



    Faculty, has the following financial relationships with commercial interests to disclose:

    Speaker's Bureau: Gilead


     

    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.07 CEU) under the ACPE universal activity number 0290-0000-22-338-H02-P. The activity is available for CE credit through July 29, 2023.


    This activity is supported by an educational grant from ViiV.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/e448bcb0-0f62-11ed-aa88-07fe75d945cd/stripped_e923312721a0145c6f0ddc8fba1f36de.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN8449231074.mp3 [size] => 81475291 [duration] => 2546.1 [uid] => CSN8449231074 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/e448bcb0-0f62-11ed-aa88-07fe75d945cd/id3/4b4640923e78b672f5c9ab3463da7061.mp3 [id3FileProcessing] => [id3FileSize] => 302690 [parentId] => [guid] => [pubdateTimezone] => [originalFilename] => HIV Prep v2.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-07-29T19:21:33.289+02:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  •  Educational Objectives·      Discuss currently available options for pre-exposure prophylaxis (PrEP) in...
  • Array ( [id] => 3fac0dc4-0f62-11ed-9658-1f4cd27d3450 [createdAt] => 2022-07-29T19:16:56.661+02:00 [updatedAt] => 2022-07-29T19:29:30.236+02:00 [title] => Caring for Patients With Multiple Myeloma Through Pharmacist-Directed Supportive Care and Toxicity Management Strategies | PTCE Pharmacy Connect [pubdate] => 2022-07-29T19:16:14.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/3fac0dc4-0f62-11ed-9658-1f4cd27d3450/image/PTCE___1_.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => Multiple Myeloma: Pharmacists as Therapy Experts [summary] =>
    • Introduction of faculty and disclosures: 
    • Dr. Kathryn Maples is a clinical pharmacy specialist in multiple myeloma at the Winship Cancer Institute with Emory Healthcare in Atlanta, Georgia.
    • Dr. Maples has the following relevant financial relationships with commercial interests to disclose: consultant for GlaxoSmithKline, Janssen, Karyopharm, and Sanofi.
    • Accreditation and support statement: 
    • PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
    • This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

     https://www.pharmacytimes.org/courses/multiple-myeloma-pharmacists-as-therapy-experts

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/3fac0dc4-0f62-11ed-9658-1f4cd27d3450/stripped_d656b5fd5a157c6cc930b39d2a289856.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN2396304941.mp3 [size] => 62019291 [duration] => 1938.1 [uid] => CSN2396304941 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/3fac0dc4-0f62-11ed-9658-1f4cd27d3450/id3/e986d3ac1e2f58070db1b20fad7d030d.mp3 [id3FileProcessing] => [id3FileSize] => 302738 [parentId] => [guid] => [pubdateTimezone] => [originalFilename] => PTCEMultipleMylomaPt.21.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-07-29T19:18:09.233+02:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Introduction of faculty and disclosures:  Dr. Kathryn Maples is a...
  • Array ( [id] => 6c0ea1a2-0dcc-11ed-9129-9fb9db82803c [createdAt] => 2022-07-27T18:51:55.458+02:00 [updatedAt] => 2022-08-09T20:05:20.909+02:00 [title] => Examining the Treatment Landscape of Metastatic NSCLC Expressing the Targetable Mutations RET, MET, and KRAS | PTCE Pharmacy Connect [pubdate] => 2022-07-29T06:00:00.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/6c0ea1a2-0dcc-11ed-9129-9fb9db82803c/image/PTCE_Josiah.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Educational Objectives

    • Review the targetable mutations RET, MET, and KRAS, including associated agents for the treatment of metastatic non-small cell lung cancer (NSCLC)

    • Discuss the ways a pharmacist may improve adherence, toxicity management, and outcomes for patients with metastatic NSCLC expressing RET, MET, and KRAS mutations

     

    Josiah D. Land, PharmD, BCOP

    Clinical Pharmacy Specialist – Thoracic Medical Oncology

    Department of Pharmacy

    Memorial Sloan Kettering Cancer Center

    New York, New York

     

    Josiah D. Land, PharmD, BCOP, has the following financial relationship with a commercial interest to disclose:

    Consultant (advisory board): Bristol Myers Squibb

     

    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number0290-0000-22-388-H01-P. The activity is available for CE credit through July 29, 2023.


     

    This activity is supported by educational funding provided by Amgen.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/6c0ea1a2-0dcc-11ed-9129-9fb9db82803c/stripped_d34531a56530b308c9f4246d972df7f2.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN2230016752.mp3 [size] => 62978925 [duration] => 1968.09 [uid] => CSN2230016752 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/6c0ea1a2-0dcc-11ed-9129-9fb9db82803c/id3/ac504ff96107e7070d7d6d45b266d0e5.mp3 [id3FileProcessing] => [id3FileSize] => 296184 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => Examining the Treatment Landscape of Metastatic NSCLC Expressing the Targetable Mutations RET, MET, and KRAS.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-08-09T20:05:19.514+02:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Educational Objectives• Review the targetable mutations RET, MET, and KRAS,...
  • Array ( [id] => 8e5a6902-0dd2-11ed-abb6-4fe2da13b746 [createdAt] => 2022-07-27T19:35:50.006+02:00 [updatedAt] => 2022-07-29T19:14:08.500+02:00 [title] => Continuing the Conversation: Optimizing Frontline Immunotherapy Outcomes in NSCLC and Managed Care Considerations | PTCE Pharmacy Connect [pubdate] => 2022-07-28T06:00:00.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/8e5a6902-0dd2-11ed-abb6-4fe2da13b746/image/PTCE.jpeg?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Educational Objectives

    ·      Review the efficacy and safety of emerging frontline immune checkpoint inhibitor (ICI) used as monotherapy and in combination regimens

    ·      Indicate the impact of ICIs and programmed death-ligand 1 testing on cost-effectiveness and patient reported outcomes related with frontline use of ICIs in advanced NSCLC

     

    Faculty:

    Paul Forsberg, PharmD, MHA, BCOP

    Director of Pharmacy

    Minnesota Oncology

    St. Paul, Minnesota

     

    Latha Radhakrishnan, PharmD, BCOP

    Clinical Oncology Pharmacist

    The University of Illinois Hospital and Health Sciences System

    Clinical Assistant Professor

    University of Illinois at Chicago College of Pharmacy

    Chicago, Illinois

     

    Paul Forsberg, PharmD, MHA, BCOP, has the following relevant financial relationships with commercial interests to disclose:

    Consultant: Epizyme

    Speakers Bureau: AstraZeneca

     

    Latha Radhakrishnan, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:

    Consultant: Taiho, Novartis, Exelixis

    Speakers Bureau: BMS, AstraZeneca, Taiho, Exelixis

     

    Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Liza Patel, PharmD, RPh; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta.

    Anonymous peer reviewers have been used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.


    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-22-363-H01-P. The activity is available for CE credit through July 29, 2023.

     

    This activity is supported by independent medical education grants from Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals, Inc., and Sanofi Genzyme.

     https://www.pharmacytimes.org/courses/continuing-the-conversation-optimizing-frontline-immunotherapy-outcomes-in-nsclc-and-managed-care-considerations

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/8e5a6902-0dd2-11ed-abb6-4fe2da13b746/stripped_9c38a271183944d6aac9db7d5d51ec6c.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN9480051597.mp3 [size] => 56803160 [duration] => 1775.1 [uid] => CSN9480051597 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/8e5a6902-0dd2-11ed-abb6-4fe2da13b746/id3/f087f0ad4c2ebd2a25a6cddac93fd4d4.mp3 [id3FileProcessing] => [id3FileSize] => 306008 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => NSCLC.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-07-29T19:14:07.737+02:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Educational Objectives·      Review the efficacy and safety of emerging frontline immune...
  • Array ( [id] => fd1f1642-09bf-11ed-b382-6f9fbfa693e5 [createdAt] => 2022-07-22T15:12:50.753+02:00 [updatedAt] => 2022-07-29T19:14:45.235+02:00 [title] => Caring for Patients With Multiple Myeloma Through Pharmacist-Directed Supportive Care and Toxicity Management Strategies | PTCE Pharmacy Connect [pubdate] => 2022-07-22T15:12:00.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/fd1f1642-09bf-11ed-b382-6f9fbfa693e5/image/PTCE___2_.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => Multiple Myeloma: Recognizing Treatment Options | PTCE Pharmacy Connect [summary] =>
    • Introduction of faculty and disclosures: 
    • Dr. Kathryn Maples is a clinical pharmacy specialist in multiple myeloma at the Winship Cancer Institute with Emory Healthcare in Atlanta, Georgia.
    • Dr. Maples has the following relevant financial relationships with commercial interests to disclose: consultant for GlaxoSmithKline, Janssen, Karyopharm, and Sanofi.
    • Accreditation and support statement: 
    • PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
    • This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

    https://www.pharmacytimes.org/courses/multiple-myeloma-recognizing-treatment-options

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/fd1f1642-09bf-11ed-b382-6f9fbfa693e5/stripped_9093aabdcbe074f3056907a5d3b11cb6.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN3317280462.mp3 [size] => 62658769 [duration] => 1958.09 [uid] => CSN3317280462 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/fd1f1642-09bf-11ed-b382-6f9fbfa693e5/id3/72de02a9a89a47cff9708520fddd3c2f.mp3 [id3FileProcessing] => [id3FileSize] => 302780 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => PTCE Multiple Myloma Pt.1.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-07-29T19:14:44.501+02:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Introduction of faculty and disclosures:  Dr. Kathryn Maples is a...
  • Array ( [id] => 748ab7d8-f88e-11ec-baed-8f6ff09a2d36 [createdAt] => 2022-06-30T18:05:26.535+02:00 [updatedAt] => 2022-07-12T21:42:00.026+02:00 [title] => The Latest Advances in the Management of Atopic Dermatitis and the Role of JAK Inhibitors: Best Practices for the Pharmacist | PTCE Pharmacy Connect [pubdate] => 2022-06-30T18:05:00.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/748ab7d8-f88e-11ec-baed-8f6ff09a2d36/image/PTCE__2_.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Educational Objectives

    ·      Understand the impact of Janus kinase inhibitors for the management of atopic dermatitis (AD)

    ·      Examine key safety and efficacy data on new and emerging Janus kinase inhibitors utilized for the treatment of AD and select appropriate treatments

    • Identify the role of the pharmacist in individualizing treatment for patients with AD through patient counseling and education

    Faculty:

    Svetlana Gerzenshtein, PharmD, BCPS, CSP

    Clinical Pharmacist Specialist

    Specialty Pharmacy Department

    University of Chicago Medical Center

    Chicago, Illinois


    Content Development

    Sarah Lant, PharmD

    Clinical Pharmacist Specialist

    UChicago Medicine

    Chicago, Illinois


    Svetlana Gerzenshtein, PharmD, BCPS, CSP, has no financial relationships with commercial interests to disclose.

    Sarah Lant, PharmD, has the following relevant financial relationship with a commercial interest to disclose:

    Other (faculty speaker training): Lily

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/748ab7d8-f88e-11ec-baed-8f6ff09a2d36/stripped_e7d8b158645362542ff1d2fa8ba842b3.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN7567237207.mp3 [size] => 67922547 [duration] => 2122.58 [uid] => CSN7567237207 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/748ab7d8-f88e-11ec-baed-8f6ff09a2d36/id3/766dee87d201fb946bdb65483c4c164b.mp3 [id3FileProcessing] => [id3FileSize] => 303035 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => Atopic Dermatitis | PTCE.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-06-30T18:05:27.398+02:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Educational Objectives·      Understand the impact of Janus kinase inhibitors for the...
  • Array ( [id] => 895aa394-f6d6-11ec-be9f-87de0d845062 [createdAt] => 2022-06-28T13:36:22.876+02:00 [updatedAt] => 2022-08-04T14:18:29.712+02:00 [title] => Continuing the Conversation | Optimizing Care for Patients With Endometrial Cancer: A Focus on Pharmacist Interventions and Mitigation of Health Equity Issues | PTCE Pharmacy Connect [pubdate] => 2022-06-30T14:17:00.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/895aa394-f6d6-11ec-be9f-87de0d845062/image/Optimizing_Care_for_Patients_with_Endometrial_Cancer.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Educational Objectives

    ·      Recognize the role of biomarker expression in the selection of most appropriate treatment options for patients with endometrial cancer

    ·      Review strategies for identification and management of drug-related toxicities in patients receiving therapy with immune checkpoint inhibitors, targeted agents, or combination therapy

      

    Faculty:

    Sarah Hayward, PharmD, BCOP

    Clinical Pharmacy Specialist, Gynecologic Oncology

    Stephenson Cancer Center at OU Health

    University of Oklahoma Health Science Center

    Oklahoma City, Oklahoma


    Sarah Hayward, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:

    Consultant (advisory board): GSK, Seagen/Genmab


    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-322-H01-P. The activity is available for CE credit through June 30, 2023.


    This educational activity is supported by an educational grant from GlaxoSmithKline

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/895aa394-f6d6-11ec-be9f-87de0d845062/stripped_919853ff1074dd04f14534e09ee9d94d.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN4677076732.mp3 [size] => 64195187 [duration] => 2006.1 [uid] => CSN4677076732 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/895aa394-f6d6-11ec-be9f-87de0d845062/id3/7cc09d298665c6502bc3f9ae201bb7cd.mp3 [id3FileProcessing] => [id3FileSize] => 303425 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => Endometrial Cancer | PTCE.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-06-28T13:36:23.369+02:00 [draft] => [externalId] => [cleanTitle] => Continuing the Conversation | Optimizing Care for Patients With Endometrial Cancer: A Focus on Pharmacist Interventions and Mitigation of Health Equity Issues [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Educational Objectives·      Recognize the role of biomarker expression in the selection...
  • Array ( [id] => 709b0fd6-f19c-11ec-8f97-6f92e98a8a84 [createdAt] => 2022-06-21T21:57:54.744+02:00 [updatedAt] => 2022-07-08T23:28:29.183+02:00 [title] => Understanding Chronic Lymphocytic Leukemia Drug Therapies | PTCE Pharmacy Connect [pubdate] => 2022-06-30T06:00:00.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/709b0fd6-f19c-11ec-8f97-6f92e98a8a84/image/PHARMACY.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>
    • Introduction of faculty and disclosures: 
    • Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida.
    • Dr. Tobon has no relevant financial relationships with commercial interests to disclose.
    • Accreditation and support statement: 
    • PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
    • This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd.
    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/709b0fd6-f19c-11ec-8f97-6f92e98a8a84/stripped_0307b7fad262a2097bc3cf26aeeda6d7.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN6794690526.mp3 [size] => 51970716 [duration] => 1624.08 [uid] => CSN6794690526 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/709b0fd6-f19c-11ec-8f97-6f92e98a8a84/id3/6992809ec9844fda1e095b1268197488.mp3 [id3FileProcessing] => [id3FileSize] => 302025 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => Leukemia | PTCE.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-06-23T18:08:53.492+02:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Introduction of faculty and disclosures:  Dr. Katherine Tobon is a...
  • Array ( [id] => bd8c1868-f619-11ec-8b8a-cf36dec185ec [createdAt] => 2022-06-27T15:04:55.574+02:00 [updatedAt] => 2022-07-08T23:28:36.316+02:00 [title] => Chronic Lymphocytic Leukemia: Insights into the Pharmacist Role in Therapy Management [pubdate] => 2022-06-30T06:00:00.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/bd8c1868-f619-11ec-8b8a-cf36dec185ec/image/PHARMACY.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>
    • Introduction of faculty and disclosures: 
    • Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida.
    • Dr. Tobon has no relevant financial relationships with commercial interests to disclose.
    • Accreditation and support statement: 
    • PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
    • This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd.
    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/bd8c1868-f619-11ec-8b8a-cf36dec185ec/stripped_507cff36e68de9f30a70788f4e77d442.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN9197973908.mp3 [size] => 51587030 [duration] => 1612.09 [uid] => CSN9197973908 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/bd8c1868-f619-11ec-8b8a-cf36dec185ec/id3/5ecfb58d90173c634a616a2f0ebc822d.mp3 [id3FileProcessing] => [id3FileSize] => 302035 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => Leukemia Part 2 | PTCE.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-06-28T13:29:38.958+02:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Introduction of faculty and disclosures:  Dr. Katherine Tobon is a...
  • Array ( [id] => 1a693ecc-f93e-11ec-9b3c-63acc7706b41 [createdAt] => 2022-07-01T15:02:46.727+02:00 [updatedAt] => 2022-07-20T17:03:51.712+02:00 [title] => The Role of JAK Inhibitors in the Management of Atopic Dermatitis [pubdate] => 2022-06-30T06:00:00.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/1a693ecc-f93e-11ec-9b3c-63acc7706b41/image/PTCE__1_.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    This podcast will specifically focus on clinical safety and efficacy data supporting the use of new and emerging JAK inhibitors in the management of AD. Practical counseling points for pharmacists to provide individualized care and proper selection of therapy to patients with AD who are initiating therapy with JAK inhibitors will also be discussed. Faculty experts will review audience questions and identify best practices in the management of AD.

    o  The Role of JAK Inhibitors in the Management of Atopic Dermatitis: Latest Advances and Best Practices for the Pharmacist

    o  Introduction of faculty, affiliations, and disclosures

    We would like to thank Sarah Lant, PharmD for her contribution in developing the content for this podcast.

    Lana Gerzenshtein, PharmD and Sarah Lant have no relevant financial relationships with commercial interests to disclose.

    o  Accreditation and support statement

    PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.

    This activity is supported by educational grants from Incyte.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/1a693ecc-f93e-11ec-9b3c-63acc7706b41/stripped_e7d8b158645362542ff1d2fa8ba842b3.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN5928376768.mp3 [size] => 67922547 [duration] => 2122.58 [uid] => CSN5928376768 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/1a693ecc-f93e-11ec-9b3c-63acc7706b41/id3/7af00440138ebb4af47b08b5d3f84adf.mp3 [id3FileProcessing] => [id3FileSize] => 303047 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => Atopic Dermatitis | PTCE.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-07-05T18:50:04.649+02:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • This podcast will specifically focus on clinical safety and efficacy...
  • Array ( [id] => aea130e0-c630-11ec-b89d-6b7f2b8ce838 [createdAt] => 2022-04-27T15:48:13.139+02:00 [updatedAt] => 2022-06-28T20:09:06.795+02:00 [title] => Where Are We Now?: The Changing Role of Pharmacists in the COVID-19 Treatment Landscape | PTCE Connect Podcast [pubdate] => 2022-04-28T06:00:00.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/aea130e0-c630-11ec-b89d-6b7f2b8ce838/image/Where_are_we_now__1_.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

     Lisa Dumkow, PharmD, BCIDP, Antimicrobial Stewardship Clinical Pharmacist, PGY-2 Infectious Diseases Pharmacy Residency Program Director, Mercy Health Saint Mary’s, Grand Rapids, MI

    Lacy Worden, PharmD, PGY-2 Infectious Diseases Pharmacy resident, Mercy Health Saint Mary’s, Grand Rapids MI [LP1] 

    Dr. Dumkow & Dr. Worden have no relevant financial relationships with commercial interests to disclose


    PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour of knowledge-based credit.

    This activity is supported by educational grants from GlaxoSmithKline.

        The educational objectives for this activity are:

    o  Examine important milestones and recent updates in the treatment and management of COVID-19

    o  Interpret safety and efficacy data for recently approved, authorized, or investigational agents for the treatment of COVID-19

    o  Illustrate how pharmacists can assist with educating patients and other health care providers regarding the latest updates to the treatment of COVID-19

    Summary statement of topic being discussed: This is a conversational interview which will focus on emerging therapies for the management of COVID-19 in the outpatient setting. A discussion around current and investigational therapies will be covered. Key takeaways and practical points will be the focus.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/aea130e0-c630-11ec-b89d-6b7f2b8ce838/stripped_f85452f61948dbb9938f422d2fb50ceb.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN4720108262.mp3 [size] => 90275004 [duration] => 2821.09 [uid] => CSN4720108262 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/aea130e0-c630-11ec-b89d-6b7f2b8ce838/id3/9d5cf55175e8f7a88d4e559b35b7b2f7.mp3 [id3FileProcessing] => [id3FileSize] => 203855 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => PTCE_Covid_FinalEdits.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-05-20T15:53:44.441+02:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  •  Lisa Dumkow, PharmD, BCIDP, Antimicrobial Stewardship Clinical Pharmacist, PGY-2 Infectious...
  • Array ( [id] => a8a85cf0-a604-11ec-a163-978c35659c0b [createdAt] => 2022-03-17T16:12:28.080+01:00 [updatedAt] => 2022-07-08T23:28:33.227+02:00 [title] => Seizure Clusters: A Review of New Drug Delivery Methods and Emerging Therapy Options | PTCE Pharmacy Connect [pubdate] => 2022-03-31T06:01:00.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/a8a85cf0-a604-11ec-a163-978c35659c0b/image/Gretchen_M._Brophy__PharmD.jpg?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Educational Objectives

    • Examine challenges in current treatment options for seizure clusters, including efficacy and safety, and differentiating routes of administration
    • Highlight considerations in treatment of seizure clusters, including addressing barriers to treatment and providing patient counseling to improve outcomes



    Faculty:

    Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FCCM, FNCS, MCCM 

    Professor

    Departments of Pharmacotherapy & Outcomes Science and Neurosurgery

    Virginia Commonwealth University, Medical College of Virginia

    Richmond, Virginia


    Neurocritical Care Clinical Pharmacist

    Virginia Commonwealth University Health

    Richmond, Virginia


    Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FCCM, FNCS, MCCM, has the following relevant financial relationships with commercial interests to disclose:

    • Grant/Research Support: Department of Defense
    • Consultant: UCB, Chiesi, Marinus, Alexion, Ceribell
    • Speakers Bureau: UCB, Chiesi


    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-129-H01-P. The activity is available for CE credit through March 31, 2023.


    This activity is supported by an educational grant from Neurelis Inc.

    Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FNCS, MCCM is Professor of Pharmacotherapy & Outcomes Sciences and Neurosurgery at Virginia Commonwealth University (VCU) School of Pharmacy, Medical College of Virginia Campus. She is a Past President of the Neurocritical Care Society. Dr. Brophy’s research interests include neuropharmacotherapy, traumatic brain injury, biomarkers, hemostasis, stroke, and status epilepticus.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/a8a85cf0-a604-11ec-a163-978c35659c0b/stripped_04a6809c15e855b9ec34d4010acd0b37.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN8121485689.mp3 [size] => 65331200 [duration] => 2041.6 [uid] => CSN8121485689 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/a8a85cf0-a604-11ec-a163-978c35659c0b/id3/026bfcc139b11a3ede7fc7e01afdc1b5.mp3 [id3FileProcessing] => [id3FileSize] => 204921 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => Seizure Clusters | PTCE.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-03-17T16:12:29.270+01:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Educational Objectives Examine challenges in current treatment options for seizure...
  • Array ( [id] => ca843c76-a3b7-11ec-b9e1-aba39c3373bd [createdAt] => 2022-03-14T17:57:11.307+01:00 [updatedAt] => 2022-03-24T14:07:55.410+01:00 [title] => Novel Non-stimulant ADHD Treatments: A Review for Pharmacists | PTCE Pharmacy Connect [pubdate] => 2022-03-30T06:01:00.000+02:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/ca843c76-a3b7-11ec-b9e1-aba39c3373bd/image/Gretchen_M._Brophy__PharmD.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Educational Objectives

    • Describe the impact of ADHD and new non-stimulant class of ADHD treatments
    • Highlight the role of the pharmacist in patient counseling, monitoring and medication management in ADHD


    Faculty:

    Sandy Mullen, PharmD, BCPP

    Clinical Pharmacy Specialist - Child and Adolescent Psychiatry 

    Department of Pharmacy 

    Virginia Commonwealth University (VCU) Health

    Richmond, VA


    Sandy Mullen, PharmD, BCPP, has no financial relationships with commercial interests to disclose.


    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-22-127-H01-P. The activity is available for CE credit through March 30, 2023.


    This activity is supported by an educational grant from Supernus.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/ca843c76-a3b7-11ec-b9e1-aba39c3373bd/stripped_7b5daa9cb5de77d6372e00c7d51d5ad4.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN9003802200.mp3 [size] => 75650612 [duration] => 2364.08 [uid] => CSN9003802200 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/ca843c76-a3b7-11ec-b9e1-aba39c3373bd/id3/60be0833ca6428ec875b3445eea66eca.mp3 [id3FileProcessing] => [id3FileSize] => 202737 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => PTCE ADHD.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-03-17T17:24:31.384+01:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Educational Objectives Describe the impact of ADHD and new non-stimulant...
  • Array ( [id] => 3b34b446-94db-11ec-a96e-07c8bdd90582 [createdAt] => 2022-02-23T20:03:05.325+01:00 [updatedAt] => 2022-07-08T23:28:26.807+02:00 [title] => Treatment and Management of ATTR: Understanding Small Interfering RNA and Emerging Therapies in the Treatment Landscape | PTCE Pharmacy Connect [pubdate] => 2022-02-28T06:01:00.000+01:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/3b34b446-94db-11ec-a96e-07c8bdd90582/image/PTCE_ATTR_Treatment.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Educational Objectives

    • Review the clinical and economic burdens associated with transthyretin amyloidosis (ATTR)

    • Recall key characteristics supporting the use of current and emerging therapies for the treatment of ATTR including mechanisms of action, clinical data, dosing, administration, and potential adverse effects


    Faculty:

    Svetlana Goldman, PharmD, BCACP, CDCES

    Clinical Pharmacist

    UC Davis Health

    Sacramento, California

    Yvette Hellier, PharmD, BCACP

    Clinical Pharmacist

    UC Davis Health

    Sacramento, California



    The following contributors have no relevant financial relationships with commercial interests to disclose: 

    Faculty

    Svetlana Goldman, PharmD, BCACP, CDCES, and Yvette Hellier, PharmD, BCACP


    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.075 CEU) under the ACPE universal activity number 0290-0000-22-045-H01-P. The activity is available for CE credit through February 28, 2023.


    This activity is supported by an educational grant from Alnylam Pharmaceuticals.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/3b34b446-94db-11ec-a96e-07c8bdd90582/stripped_d9de10c411157d6730feb654afd0d7d0.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN6145600770.mp3 [size] => 83042638 [duration] => 2595.08 [uid] => CSN6145600770 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/3b34b446-94db-11ec-a96e-07c8bdd90582/id3/e8d9ad3a62a811326aaba47f455b9053.mp3 [id3FileProcessing] => [id3FileSize] => 203577 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => Treatment Management of ATTR PharmD | PTCE Connect.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-02-24T14:09:54.592+01:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Educational Objectives• Review the clinical and economic burdens associated with...
  • Array ( [id] => aff73698-94d9-11ec-96b5-0f460ef38178 [createdAt] => 2022-02-23T19:52:02.209+01:00 [updatedAt] => 2022-07-08T23:28:34.212+02:00 [title] => New and Emerging Non-Opioid Treatment Strategies for Pain Management: An Update for Pharmacists | PTCE Pharmacy Connect [pubdate] => 2022-02-24T14:06:00.000+01:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/aff73698-94d9-11ec-96b5-0f460ef38178/image/PTCE_Non-Opioid_Pain_Management.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Educational Objectives

    • Describe the impact of COVID-19 on surgical pain management 
    • Review current postoperative pain management guidelines and emerging non-opioid treatment approaches for pain management, including safety and efficacy data on newer treatments, and key considerations for pharmacists


    Faculty:

    Jawad N. Saleh, PharmD, BS, BCPS, BCCCP

    Clinical Manager of Pharmacy Services

    Pharmacy Department

    The Hospital for Special Surgery

    New York, New York



    Faculty, has the following financial relationships with commercial interests to disclose:

    Jawad N. Saleh, PharmD, BS, BCPS, BCCCP, has the following relevant financial relationships with commercial interests to disclose:

    Consultant: Heron Therapeutics, Baudax Bio

    Speakers Bureau: Heron Therapeutics, Baudax Bio

    Scientific Advisory Boards: Heron Therapeutics, Baudax Bio


    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.075 CEU) under the ACPE universal activity number 0290-0000-22-046-H08-P. The activity is available for CE credit through February 24, 2023.


    This activity is supported by an educational grant from Heron.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/aff73698-94d9-11ec-96b5-0f460ef38178/stripped_e058e06d1f4ecf818b445f3a18826e79.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN2805231456.mp3 [size] => 70530612 [duration] => 2204.08 [uid] => CSN2805231456 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/aff73698-94d9-11ec-96b5-0f460ef38178/id3/de6d35d6a1a388125f88952ab936eaf6.mp3 [id3FileProcessing] => [id3FileSize] => 203703 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => Pain Management Dr. Jawad Saleh PharmD | PTCE Connect.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-02-24T14:06:05.124+01:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Educational Objectives Describe the impact of COVID-19 on surgical pain...
  • Array ( [id] => 8436cc1a-73b1-11ec-96d4-8bb9143df49a [createdAt] => 2022-01-12T15:11:20.510+01:00 [updatedAt] => 2022-07-08T23:28:31.348+02:00 [title] => The Promising Role of Microbiome-Based Drugs for the Treatment and Prevention of Recurrent Clostridioides Difficile | PTCE Pharmacy Connect [pubdate] => 2022-01-31T17:49:00.000+01:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/8436cc1a-73b1-11ec-96d4-8bb9143df49a/image/CSR-PTCE-Pharmacy-Connect.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Educational Objectives

    • Discuss the role of disruptions in the gut microbiome in the development of Clostridioides difficile infection (CDI) and recurrent CDIs
    • Review the efficacy, safety, and role of fecal microbiota transplantation and emerging microbiome-based drugs for treatment of CDIs and rCDIs


    Faculty:

    Kevin W. Garey, PharmD, MS

    Professor and Chair

    University of Houston College of Pharmacy 

    Houston, Texas


    Kevin W. Garey, PharmD, MS, has the following relevant financial relationships with commercial interests to disclose:

    Grant/Research Support: Summit, Acurx, and Parakek Pharmaceuticals, and Seres Therapeutics

    Consultant: Ferring Pharmaceuticals


    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hour (0.075 CEU) under the ACPE universal activity number 0290-0000-22-048-H01-P. The activity is available for CE credit through January 31, 2023.


    This activity is supported by a medical education grant from Ferring Pharmaceuticals.

    Participants can claim credit for this CE activity by following the link below:

    https://www.pharmacytimes.org/courses/the-promising-role-of-microbiome-based-drugs-for-the-treatment-and-prevention-of-recurrent-clostridioides-difficile

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/8436cc1a-73b1-11ec-96d4-8bb9143df49a/stripped_927a0a36375148e60492c878b49ee0ae.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN2397392553.mp3 [size] => 78083134 [duration] => 2440.1 [uid] => CSN2397392553 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/8436cc1a-73b1-11ec-96d4-8bb9143df49a/id3/a99948966b19939c06b4639a60d1e625.mp3 [id3FileProcessing] => [id3FileSize] => 204133 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => CDI Podcast Discussion Guide | PTCE Connect.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2022-02-02T17:27:42.921+01:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Educational Objectives Discuss the role of disruptions in the gut...
  • Array ( [id] => 2a4f8d76-6426-11ec-a03d-df460a16e40e [createdAt] => 2021-12-23T20:26:02.203+01:00 [updatedAt] => 2022-07-08T23:28:25.027+02:00 [title] => Proactive Management of Adverse Effects Associated With Waldenström Macroglobulinemia | PTCE Pharmacy Connect [pubdate] => 2021-12-23T20:26:00.000+01:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Educational Objective

    • Identify best practices for managing toxicities associated with therapies for the treatment of Waldenström macroglobulinemia

     

    Faculty: Victoria Nachar, PharmD, BCOP

    Clinical Pharmacist Specialist, Ambulatory Hematology Oncology

    University of Michigan Rogel Cancer Center

    Clinical Assistant Professor

    University of Michigan College of Pharmacy

    Ann Arbor, Michigan


    Faculty has no financial relationships with commercial interests to disclose.





    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-21-457-H01-P. The activity is available for CE credit through June 20, 2022.


    This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc; and BeiGene, Ltd.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/2a4f8d76-6426-11ec-a03d-df460a16e40e/stripped_5b362db4cb880cdc53e811c47946c278.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN2146650559.mp3 [size] => 60995291 [duration] => 1906.1 [uid] => CSN2146650559 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/2a4f8d76-6426-11ec-a03d-df460a16e40e/id3/41a726b5c8048ede440dcacb630e5434.mp3 [id3FileProcessing] => [id3FileSize] => 202641 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => Waldenstrom part TWO| PTCE Connect.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2021-12-23T20:26:03.231+01:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Educational ObjectiveIdentify best practices for managing toxicities associated with therapies...
  • Array ( [id] => 0f1e6384-61cd-11ec-b54e-d38be65903e6 [createdAt] => 2021-12-20T20:43:09.045+01:00 [updatedAt] => 2022-07-08T23:28:22.417+02:00 [title] => Strategies for Pharmacist Involvement in Adverse Effect Management | PTCE Pharmacy Connect [pubdate] => 2021-12-20T20:42:10.000+01:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/0f1e6384-61cd-11ec-b54e-d38be65903e6/image/Strategies_for_Pharmacist_Involvement_in_Adverse_Effect_Management.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Educational Objectives

    ·            Recognize best practices for managing adverse effects associated with immune checkpoint inhibitor (ICI)-targeted therapy combinations

     

    Faculty:

    Jacob K. Kettle, PharmD, BCOP

    Pharmacy Manager

    Ellis Fischel Cancer Center

    Department of Pharmacy

    University of Missouri Health Care

    Columbia, Missouri

     

    Faculty, has the following financial relationships with commercial interests to disclose:

    Jacob Kettle, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:

    Speakers Bureau: Genentech, Merck, Amgen, Lilly, DSI

    Consultant: Pfizer, Lilly


    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-21-438-H01-P. The activity is available for CE credit through December 17, 2022.

    This activity is supported by educational grants from Eisai Inc and Exelixis, Inc.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/0f1e6384-61cd-11ec-b54e-d38be65903e6/stripped_304b02fc470191de0b9f0fd53ef18344.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN1085877284.mp3 [size] => 76355291 [duration] => 2386.1 [uid] => CSN1085877284 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/0f1e6384-61cd-11ec-b54e-d38be65903e6/id3/94a0eca86c3643d9198562987acec1f4.mp3 [id3FileProcessing] => [id3FileSize] => 202891 [parentId] => [guid] => [pubdateTimezone] => [originalFilename] => Dr.JacobKettlePartTwoPTCEConnect.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2021-12-20T20:43:09.650+01:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Educational Objectives·            Recognize best practices for managing adverse effects associated with...
  • Array ( [id] => b956917e-61cc-11ec-a20a-670761e343cf [createdAt] => 2021-12-20T20:40:45.114+01:00 [updatedAt] => 2022-07-08T23:28:35.603+02:00 [title] => Establishing the Role of Targeted Therapies in Cancer Care | PTCE Pharmacy Connect [pubdate] => 2021-12-18T06:00:00.000+01:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/b956917e-61cc-11ec-a20a-670761e343cf/image/Establishing_the_Role_of_Targeted_Therapies_in_Cancer_Care_.png?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Educational Objectives

    ·             Describe the role of immune checkpoint inhibitor (ICI)-targeted therapy combinations across malignancies

    ·             Recall knowledge of ICI-targeted therapy combinations to treatment selection in patients with cancer

     

    Faculty:

    Jacob K. Kettle, PharmD, BCOP

    Pharmacy Manager

    Ellis Fischel Cancer Center

    Department of Pharmacy

    University of Missouri Health Care

    Columbia, Missouri


    Faculty, has the following financial relationships with commercial interests to disclose:

    Jacob Kettle, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:

    Speakers Bureau: Genentech, Merck, Amgen, Lilly, DSI

    Consultant: Pfizer, Lilly


    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-437-H01-P. The activity is available for CE credit through December 17, 2022.

    This activity is supported by educational grants from Eisai Inc and Exelixis, Inc.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/b956917e-61cc-11ec-a20a-670761e343cf/stripped_e57bb9540fcca692539d52290092ef5e.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN1610009300.mp3 [size] => 59747265 [duration] => 1867.1 [uid] => CSN1610009300 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/b956917e-61cc-11ec-a20a-670761e343cf/id3/133c31bad596cf3a71a02e485db4a153.mp3 [id3FileProcessing] => [id3FileSize] => 203029 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => Dr.JacobKettlePTCEConnect.mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2021-12-20T20:40:45.688+01:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Educational Objectives·             Describe the role of immune checkpoint inhibitor (ICI)-targeted therapy...
  • Array ( [id] => 45d1adee-5cf2-11ec-86aa-c312c7dd2f85 [createdAt] => 2021-12-14T16:26:56.372+01:00 [updatedAt] => 2022-07-08T23:28:28.617+02:00 [title] => Waldenström Macroglobulinemia and Treatment Advancements with the Use of BTK Inhibitors | PTCE Pharmacy Connect [pubdate] => 2021-12-14T16:43:46.000+01:00 [link] => [author] => Pharmacy Podcast Network [imageFile] => [explicit] => [episodeType] => full [seasonNumber] => [episodeNumber] => [subtitle] => [summary] =>

    Pharmacy Times Continuing Education™ (PTCE) provides industry-leading pharmacy CE to retail, oncology, managed care, specialty, and health-system pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.


    Podcast 1: Waldenström Macroglobulinemia and Treatment Advancements with the Use of BTK Inhibitors

    Educational Objectives

    ·             Outline the pathophysiology of Waldenström macroglobulinemia (WM) and its connection to use of new and emerging drug therapies

    ·             Review clinical guidelines and treatment selection in patients with WM


    Faculty: Victoria Nachar, PharmD, BCOP

    Clinical Pharmacist Specialist, Ambulatory Hematology Oncology

    University of Michigan Rogel Cancer Center

    Clinical Assistant Professor

    University of Michigan College of Pharmacy

    Ann Arbor, Michigan

     

    Faculty has no financial relationships with commercial interests to disclose.


    Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-21-441-H01-P. The activity is available for CE credit through June 13, 2022. 

    This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc; and BeiGene, Ltd.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/45d1adee-5cf2-11ec-86aa-c312c7dd2f85/stripped_a344caa332eb68c1766f86d374dee39b.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN9601616945.mp3 [size] => 51394769 [duration] => 1606.09 [uid] => CSN9601616945 [originalUrl] => [bitrate] => 256 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/45d1adee-5cf2-11ec-86aa-c312c7dd2f85/id3/24fe3e06b8d03da63597817d336b768f.mp3 [id3FileProcessing] => [id3FileSize] => 204081 [parentId] => [guid] => [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => WaldenstromEpisode1 (1).mp3 [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2021-12-14T16:26:56.884+01:00 [draft] => [externalId] => [cleanTitle] => [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Pharmacy Times Continuing Education™ (PTCE) provides industry-leading pharmacy CE to...
  • Array ( [id] => 80da251c-3351-11ec-b33f-031370d1dc38 [createdAt] => 2021-10-22T18:02:48.758+02:00 [updatedAt] => 2021-11-24T16:33:23.208+01:00 [title] => Optimizing Care for People Living with HIV: Beyond Typical Risk Factors for Weight Gain | PTCE Pharmacy Connect [pubdate] => 2021-08-31T23:19:00.000+02:00 [link] => https://omny.fm/shows/pharmacy-podcast-network/optimizing-care-for-people-living-with-hiv-beyond [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/80da251c-3351-11ec-b33f-031370d1dc38/image/image.jpg?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => 12 [episodeNumber] => 1403 [subtitle] => Optimizing Care for People Living with HIV: Beyond Typical Risk Factors for Weight Gain | PTCE ConnectEducational ObjectivesDescribe recent data surrounding weight gain among people living with HIV (PLWH) who are on antiretroviral therapyRecognize the role of the pharmacist in the care of PLWHContinuing the Conversation – Individualizing the Management of HIV: A Focus on Weight GainIntroduction of faculty, affiliations, and disclosuresDr. David Koren, PharmD, MPH, BCPS, AAHIVP, Clinical Pharmacist Specialist in Infectious Diseases at the Temple University Health System, Philadelphia, PennsylvaniaDr. Koren has the following relevant financial relationships with commercial interests to disclose:Advisory Boards: Gilead, Thera, and ViiVIndependent consulting: AbbVie and TheraAccreditation and support statementPTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 credit hours of knowledge-based credit.This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.Access PTCE here: https://www.pharmacytimes.org/on-demand/continuing-the-conversation-individualizing-the-management-of-hiv-a-focus-on-weight-gainSee omnystudio.com/listener for privacy information. [summary] =>

    Optimizing Care for People Living with HIV: Beyond Typical Risk Factors for Weight Gain | PTCE Connect Educational Objectives Describe recent data surrounding weight gain among people living with HIV (PLWH) who are on antiretroviral therapy Recognize the role of the pharmacist in the care of PLWH Continuing the Conversation – Individualizing the Management of HIV: A Focus on Weight Gain Introduction of faculty, affiliations, and disclosures Dr. David Koren, PharmD, MPH, BCPS, AAHIVP, Clinical Pharmacist Specialist in Infectious Diseases at the Temple University Health System, Philadelphia, Pennsylvania Dr. Koren has the following relevant financial relationships with commercial interests to disclose: Advisory Boards: Gilead, Thera, and ViiV Independent consulting: AbbVie and Thera Accreditation and support statement PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 credit hours of knowledge-based credit. This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP. Access PTCE here: https://www.pharmacytimes.org/on-demand/continuing-the-conversation-individualizing-the-management-of-hiv-a-focus-on-weight-gain See omnystudio.com/listener for privacy information.

    [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/80da251c-3351-11ec-b33f-031370d1dc38/stripped_e33742c67827a086d0b640d0e69d450d.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN3587900421.mp3 [size] => 27520522 [duration] => 1720.03 [uid] => CSN3587900421 [originalUrl] => https://chrt.fm/track/9E721/traffic.omny.fm/d/clips/1eb5bacd-67ef-4d44-bf2a-a9f2000e0bb8/205ebaaa-1735-4516-9d9e-a9f8015d6a71/bff2cbba-8737-463f-ba2c-ad8600e363c6/audio.mp3?utm_source=Podcast&in_playlist=84d2a465-54cf-41dd-b741-aa870121de98 [bitrate] => 128 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/80da251c-3351-11ec-b33f-031370d1dc38/id3/297ffd87f21878f97b2328da259a073f.mp3 [id3FileProcessing] => [id3FileSize] => 205665 [parentId] => [guid] => bff2cbba-8737-463f-ba2c-ad8600e363c6 [pubdateTimezone] => Eastern Time (US & Canada) [originalFilename] => [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2021-11-24T16:33:22.999+01:00 [draft] => [externalId] => [cleanTitle] => Optimizing Care for People Living with HIV: Beyond Typical Risk Factors for Weight Gain | PTCE Pharmacy Connect [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Optimizing Care for People Living with HIV: Beyond Typical Risk...
  • Array ( [id] => 8139d958-3351-11ec-b33f-271361e0ac79 [createdAt] => 2021-10-22T18:02:49.403+02:00 [updatedAt] => 2021-10-22T18:03:18.972+02:00 [title] => The Impact of COVID-19 Vaccine Hesitancy and Overcoming Patient Barriers | PTCE Connect [pubdate] => 2021-07-20T18:19:00.000+02:00 [link] => https://omny.fm/shows/pharmacy-podcast-network/the-impact-of-covid-19-vaccine-hesitancy-and-overc [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/8139d958-3351-11ec-b33f-271361e0ac79/image/image.jpg?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => 12 [episodeNumber] => 1385 [subtitle] => Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. Educational Objectives: Discuss the various barriers to COVID-19 vaccine uptake including reasons for vaccine hesitancy Review how pharmacists can address the reluctance of COVID-19 vaccination in communities Faculty: Rachel Armstrong, PsyD Clinical Psychologist Portsmouth, NH Rachel Armstrong, PsyD, has no financial relationships with commercial interests to disclose. Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-283-H06-P. The activity is available for CE credit through July 29, 2022. This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP. See omnystudio.com/listener for privacy information. [summary] => Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. Educational Objectives: Discuss the various barriers to COVID-19 vaccine uptake including reasons for vaccine hesitancy Review how pharmacists can address the reluctance of COVID-19 vaccination in communities Faculty: Rachel Armstrong, PsyD Clinical Psychologist Portsmouth, NH Rachel Armstrong, PsyD, has no financial relationships with commercial interests to disclose. Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-283-H06-P. The activity is available for CE credit through July 29, 2022. This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP. See omnystudio.com/listener for privacy information. [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/8139d958-3351-11ec-b33f-271361e0ac79/stripped_82881725968b8829886ec83e211f2898.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN1482720686.mp3 [size] => 26220669 [duration] => 1638.79 [uid] => CSN1482720686 [originalUrl] => https://chrt.fm/track/9E721/traffic.omny.fm/d/clips/1eb5bacd-67ef-4d44-bf2a-a9f2000e0bb8/205ebaaa-1735-4516-9d9e-a9f8015d6a71/32e11232-157d-447c-ba28-ad6701261ab3/audio.mp3?utm_source=Podcast&in_playlist=84d2a465-54cf-41dd-b741-aa870121de98 [bitrate] => 128 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/8139d958-3351-11ec-b33f-271361e0ac79/id3/68a4aaa82d2f408013c34202cb09fbda.mp3 [id3FileProcessing] => [id3FileSize] => 60547 [parentId] => [guid] => 32e11232-157d-447c-ba28-ad6701261ab3 [pubdateTimezone] => [originalFilename] => [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2021-10-22T18:02:55.883+02:00 [draft] => [externalId] => [cleanTitle] => The Impact of COVID-19 Vaccine Hesitancy and Overcoming Patient Barriers | PTCE Connect [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE...
  • Array ( [id] => 81aba614-3351-11ec-b33f-0f1812668029 [createdAt] => 2021-10-22T18:02:50.142+02:00 [updatedAt] => 2021-10-22T18:03:21.219+02:00 [title] => Adverse Effects versus Convenience of the COVID-19 Viral-Vector Vaccines | PTCE Connect [pubdate] => 2021-06-29T06:01:00.000+02:00 [link] => https://omny.fm/shows/pharmacy-podcast-network/adverse-effects-versus-convenience-of-the-covid-19 [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/81aba614-3351-11ec-b33f-0f1812668029/image/image.jpg?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => 12 [episodeNumber] => 1355 [subtitle] => Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. Adverse Effects versus Convenience of the COVID-19 Viral-Vector Vaccines Educational Objectives: Articulate the benefits of viral-vector vaccines compared with the risk of thrombosis with thrombocytopenia syndrome (TTS) Elaborate on current viral-vector TTS adverse effect incidence data and risk among patients who have received or will receive a viral-vector vaccine  Faculty: James Lewis, PharmD, FIDSA ID Clinical Pharmacy Supervisor Oregon Health & Sciences University Portland, Oregon James Lewis, PharmD, FIDSA, has no financial relationships with commercial interests to disclose. Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-264-H06-P. The activity is available for CE credit through June 29, 2022. This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP. See omnystudio.com/listener for privacy information. [summary] => Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. Adverse Effects versus Convenience of the COVID-19 Viral-Vector Vaccines Educational Objectives: Articulate the benefits of viral-vector vaccines compared with the risk of thrombosis with thrombocytopenia syndrome (TTS) Elaborate on current viral-vector TTS adverse effect incidence data and risk among patients who have received or will receive a viral-vector vaccine  Faculty: James Lewis, PharmD, FIDSA ID Clinical Pharmacy Supervisor Oregon Health & Sciences University Portland, Oregon James Lewis, PharmD, FIDSA, has no financial relationships with commercial interests to disclose. Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-264-H06-P. The activity is available for CE credit through June 29, 2022. This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP. See omnystudio.com/listener for privacy information. [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/81aba614-3351-11ec-b33f-0f1812668029/stripped_150e2b8e6397342e119f9ebd64fe4fc9.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN8612826700.mp3 [size] => 20001854 [duration] => 1250.12 [uid] => CSN8612826700 [originalUrl] => https://chrt.fm/track/9E721/traffic.omny.fm/d/clips/1eb5bacd-67ef-4d44-bf2a-a9f2000e0bb8/205ebaaa-1735-4516-9d9e-a9f8015d6a71/5eeddbd9-156f-4a55-ba77-ad490124a10a/audio.mp3?utm_source=Podcast&in_playlist=84d2a465-54cf-41dd-b741-aa870121de98 [bitrate] => 128 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/81aba614-3351-11ec-b33f-0f1812668029/id3/7278bbf19418bbe180f0466d73bde015.mp3 [id3FileProcessing] => [id3FileSize] => 61431 [parentId] => [guid] => 5eeddbd9-156f-4a55-ba77-ad490124a10a [pubdateTimezone] => [originalFilename] => [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2021-10-22T18:02:55.813+02:00 [draft] => [externalId] => [cleanTitle] => Adverse Effects versus Convenience of the COVID-19 Viral-Vector Vaccines | PTCE Connect [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE...
  • Array ( [id] => 82211480-3351-11ec-b33f-eb9bd250788b [createdAt] => 2021-10-22T18:02:50.917+02:00 [updatedAt] => 2021-10-22T18:03:30.253+02:00 [title] => Implementing Digital Technology Tools within Health-Systems for Improving Adherence and Patient Support | PTCE Pharmacy Connect [pubdate] => 2021-05-25T16:36:00.000+02:00 [link] => https://omny.fm/shows/pharmacy-podcast-network/optimizing-safety-efficacy-of-btk-inhibitors-par-1 [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/82211480-3351-11ec-b33f-eb9bd250788b/image/image.jpg?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => 12 [episodeNumber] => 1302 [subtitle] => Implementing Digital Technology Tools within Health-Systems for Improving Adherence and Patient Support Educational Objectives: At the completion of this activity, participants will be able to: Define the pharmacist’s role in implementing digital and telemedicine technologies within the health system to improve adherence and provide remote patient monitoring and management. Anthony J. Perissinotti, PharmD, BCOP is a Clinical Pharmacist Specialist, Hematology and the Clinical Team Leader Hematology/Oncology as well as an Adjunct Clinical Assistant Professor at the University of Michigan - Michigan Medicine in Ann Arbor, Michigan He has no relevant financial relationships with commercial interests to disclose. PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours of knowledge-based credit. Click here to view the activity on the PTCE website and claim your credit: https://www.pharmacytimes.org/on-demand/bcell-malignancies-podcast-part2 This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc and Beigene. See omnystudio.com/listener for privacy information. [summary] => Implementing Digital Technology Tools within Health-Systems for Improving Adherence and Patient Support Educational Objectives: At the completion of this activity, participants will be able to: Define the pharmacist’s role in implementing digital and telemedicine technologies within the health system to improve adherence and provide remote patient monitoring and management. Anthony J. Perissinotti, PharmD, BCOP is a Clinical Pharmacist Specialist, Hematology and the Clinical Team Leader Hematology/Oncology as well as an Adjunct Clinical Assistant Professor at the University of Michigan - Michigan Medicine in Ann Arbor, Michigan He has no relevant financial relationships with commercial interests to disclose. PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours of knowledge-based credit. Click here to view the activity on the PTCE website and claim your credit: https://www.pharmacytimes.org/on-demand/bcell-malignancies-podcast-part2 This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc and Beigene. See omnystudio.com/listener for privacy information. [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/82211480-3351-11ec-b33f-eb9bd250788b/stripped_923b0baf0f6c36a34e08845ac851ddbb.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN1452114794.mp3 [size] => 39553985 [duration] => 2472.12 [uid] => CSN1452114794 [originalUrl] => https://chrt.fm/track/9E721/traffic.omny.fm/d/clips/1eb5bacd-67ef-4d44-bf2a-a9f2000e0bb8/205ebaaa-1735-4516-9d9e-a9f8015d6a71/4f2ff8ca-c9d1-4b9c-9a2f-ad1300fb1d8b/audio.mp3?utm_source=Podcast&in_playlist=84d2a465-54cf-41dd-b741-aa870121de98 [bitrate] => 128 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/82211480-3351-11ec-b33f-eb9bd250788b/id3/f362f01760b9a66e5940b20a2ab46726.mp3 [id3FileProcessing] => [id3FileSize] => 60819 [parentId] => [guid] => 4f2ff8ca-c9d1-4b9c-9a2f-ad1300fb1d8b [pubdateTimezone] => [originalFilename] => [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2021-10-22T18:02:56.468+02:00 [draft] => [externalId] => [cleanTitle] => Implementing Digital Technology Tools within Health-Systems for Improving Adherence and Patient Support | PTCE Pharmacy Connect [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Implementing Digital Technology Tools within Health-Systems for Improving Adherence and...
  • Array ( [id] => 829d39ac-3351-11ec-b33f-cf823accec1f [createdAt] => 2021-10-22T18:02:51.730+02:00 [updatedAt] => 2021-10-22T18:03:35.204+02:00 [title] => Optimizing Safety & Efficacy of BTK Inhibitors | PTCE Pharmacy Connect [pubdate] => 2021-05-25T16:35:00.000+02:00 [link] => https://omny.fm/shows/pharmacy-podcast-network/optimizing-safety-efficacy-of-btk-inhibitors-part [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/829d39ac-3351-11ec-b33f-cf823accec1f/image/image.jpg?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => 12 [episodeNumber] => 1308 [subtitle] => Foundations of Evidence for the Use of BTK Inhibitors in B-Cell Malignancies and Management Strategies for Cardiac and Bleeding Adverse Effects Educational Objectives: At the completion of this activity, participants will be able to: Outline the efficacy of oral BTK inhibitors across B-cell malignancies including a focus on emerging clinical data Recognize pharmacists’ responsibilities for monitoring and managing cardiac adverse effects specific to different health-system practice types Anthony J. Perissinotti, PharmD, BCOP is a Clinical Pharmacist Specialist, Hematology and the Clinical Team Leader Hematology/Oncology as well as an Adjunct Clinical Assistant Professor at the University of Michigan - Michigan Medicine in Ann Arbor, Michigan He has no relevant financial relationships with commercial interests to disclose. PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours of knowledge-based credit. Click here to view the activity on the PTCE website and claim your credit: https://www.pharmacytimes.org/on-demand/bcell-malignancies-podcast-part1 This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc and Beigene. See omnystudio.com/listener for privacy information. [summary] => Foundations of Evidence for the Use of BTK Inhibitors in B-Cell Malignancies and Management Strategies for Cardiac and Bleeding Adverse Effects Educational Objectives: At the completion of this activity, participants will be able to: Outline the efficacy of oral BTK inhibitors across B-cell malignancies including a focus on emerging clinical data Recognize pharmacists’ responsibilities for monitoring and managing cardiac adverse effects specific to different health-system practice types Anthony J. Perissinotti, PharmD, BCOP is a Clinical Pharmacist Specialist, Hematology and the Clinical Team Leader Hematology/Oncology as well as an Adjunct Clinical Assistant Professor at the University of Michigan - Michigan Medicine in Ann Arbor, Michigan He has no relevant financial relationships with commercial interests to disclose. PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours of knowledge-based credit. Click here to view the activity on the PTCE website and claim your credit: https://www.pharmacytimes.org/on-demand/bcell-malignancies-podcast-part1 This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc and Beigene. See omnystudio.com/listener for privacy information. [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/829d39ac-3351-11ec-b33f-cf823accec1f/stripped_3034ac866b656ea4fe69ad2a199fc903.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN4270637441.mp3 [size] => 45057671 [duration] => 2816.1 [uid] => CSN4270637441 [originalUrl] => https://chrt.fm/track/9E721/traffic.omny.fm/d/clips/1eb5bacd-67ef-4d44-bf2a-a9f2000e0bb8/205ebaaa-1735-4516-9d9e-a9f8015d6a71/a677792f-2e31-4b4b-bb6e-ad160137bcf8/audio.mp3?utm_source=Podcast&in_playlist=84d2a465-54cf-41dd-b741-aa870121de98 [bitrate] => 128 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/829d39ac-3351-11ec-b33f-cf823accec1f/id3/0694190b97ad86be98f6cb4da45d9add.mp3 [id3FileProcessing] => [id3FileSize] => 61165 [parentId] => [guid] => a677792f-2e31-4b4b-bb6e-ad160137bcf8 [pubdateTimezone] => [originalFilename] => [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2021-10-22T18:02:56.822+02:00 [draft] => [externalId] => [cleanTitle] => Optimizing Safety & Efficacy of BTK Inhibitors | PTCE Pharmacy Connect [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Foundations of Evidence for the Use of BTK Inhibitors in...
  • Array ( [id] => 83903e18-3351-11ec-b33f-1f83423663b8 [createdAt] => 2021-10-22T18:02:53.311+02:00 [updatedAt] => 2021-10-22T18:03:25.625+02:00 [title] => Continuous Glucose Monitors in Diabetes Management | PTCE Pharmacy Connect [pubdate] => 2021-04-30T06:01:00.000+02:00 [link] => https://omny.fm/shows/pharmacy-podcast-network/continuous-glucose-monitors-in-diabetes-management [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/83903e18-3351-11ec-b33f-1f83423663b8/image/image.jpg?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => 12 [episodeNumber] => 1303 [subtitle] => Continuous Glucose Monitoring:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes in Diabetes Management   Objectives  Describe the use of continuous glucose monitoring (CGM) in diabetes management and ADA/AACE recommendations Recognize the role of the pharmacist in providing education related to the use of CGM devices and interpreting CGM data Faculty Disclosures Curtis L. Triplitt, PharmD, has the following relevant financial relationships with commercial interests to disclose: Consultant: Bayer Speaker’s Bureau: Eli Lilly, NovoNordisk Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following relevant financial relationships with commercial interests to disclose: Speaker’s Bureau: Novo Nordisk, Inc. Other Support: Advanced Practitioner Advisory Board- Novo Nordisk, Inc. PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for .5 contact hours of knowledge-based credit. This activity is supported by an independent educational grant from Abbott Diabetes Care Inc. Learn more here: https://www.pharmacytimes.org/on-demand/continuous-glucose-monitoring-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-in-diabetes-management Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.  See omnystudio.com/listener for privacy information. [summary] => Continuous Glucose Monitoring:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes in Diabetes Management   Objectives  Describe the use of continuous glucose monitoring (CGM) in diabetes management and ADA/AACE recommendations Recognize the role of the pharmacist in providing education related to the use of CGM devices and interpreting CGM data Faculty Disclosures Curtis L. Triplitt, PharmD, has the following relevant financial relationships with commercial interests to disclose: Consultant: Bayer Speaker’s Bureau: Eli Lilly, NovoNordisk Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following relevant financial relationships with commercial interests to disclose: Speaker’s Bureau: Novo Nordisk, Inc. Other Support: Advanced Practitioner Advisory Board- Novo Nordisk, Inc. PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for .5 contact hours of knowledge-based credit. This activity is supported by an independent educational grant from Abbott Diabetes Care Inc. Learn more here: https://www.pharmacytimes.org/on-demand/continuous-glucose-monitoring-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-in-diabetes-management Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.  See omnystudio.com/listener for privacy information. [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/83903e18-3351-11ec-b33f-1f83423663b8/stripped_29d3f468c703d67b01834728a0ea0ba4.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN4947035679.mp3 [size] => 24737750 [duration] => 1546.11 [uid] => CSN4947035679 [originalUrl] => https://chrt.fm/track/9E721/traffic.omny.fm/d/clips/1eb5bacd-67ef-4d44-bf2a-a9f2000e0bb8/205ebaaa-1735-4516-9d9e-a9f8015d6a71/d1c77aa3-f7aa-4c0e-8f69-ad1301065a9d/audio.mp3?utm_source=Podcast&in_playlist=84d2a465-54cf-41dd-b741-aa870121de98 [bitrate] => 128 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/83903e18-3351-11ec-b33f-1f83423663b8/id3/f1e325994855000c6f148a49fecf237f.mp3 [id3FileProcessing] => [id3FileSize] => 62413 [parentId] => [guid] => d1c77aa3-f7aa-4c0e-8f69-ad1301065a9d [pubdateTimezone] => [originalFilename] => [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2021-10-22T18:02:57.516+02:00 [draft] => [externalId] => [cleanTitle] => Continuous Glucose Monitors in Diabetes Management | PTCE Pharmacy Connect [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Continuous Glucose Monitoring:Understanding the Pharmacist’s Role in Patient Education and...
  • Array ( [id] => 83fd4242-3351-11ec-b33f-db405d357112 [createdAt] => 2021-10-22T18:02:54.033+02:00 [updatedAt] => 2021-10-22T18:03:28.238+02:00 [title] => PCSK9 Inhibitors | Pharmacy Connect Podcast [pubdate] => 2020-12-22T06:01:00.000+01:00 [link] => https://omny.fm/shows/pharmacy-podcast-network/pcsk9-inhibitors-pharmacy-connect-podcast [author] => Pharmacy Podcast Network [imageFile] => https://megaphone.imgix.net/podcasts/83fd4242-3351-11ec-b33f-db405d357112/image/image.jpg?ixlib=rails-2.1.2 [explicit] => [episodeType] => full [seasonNumber] => 11 [episodeNumber] => 1185 [subtitle] => Pharmacy Connect Podcast: PCSK9 Inhibitors Title: PCSK9 Inhibitors:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes With Hyperlipidemia Management  Special guest: Joseph Saseen, PharmD Professor and Vice Chair, Clinical and Academic Programs; Department of Clinical Pharmacy        Skaggs School of Pharmacy and Pharmaceutical Sciences       University of Colorado Anschutz Medical Campus Objectives Understand the role of PCSK9 inhibitors in the American Heart Association and the American College of Cardiology hyperlipidemia management guidelines Review the pertinent drug information and clinical benefits of the use of PCSK9 inhibitors in the treatment of hyperlipidemia. Describe the role of the pharmacist in patient education and counseling on PCSK9 inhibitors for the treatment of hyperlipidemia through motivational interviewing. CE LINK HERE: https://www.pharmacytimes.org/on-demand/pcsk9-inhibitors-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-with-hyperlipidemia-management  PTCE - Pharmacy Times Continuing Education  See omnystudio.com/listener for privacy information. [summary] => Pharmacy Connect Podcast: PCSK9 Inhibitors Title: PCSK9 Inhibitors:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes With Hyperlipidemia Management  Special guest: Joseph Saseen, PharmD Professor and Vice Chair, Clinical and Academic Programs; Department of Clinical Pharmacy        Skaggs School of Pharmacy and Pharmaceutical Sciences       University of Colorado Anschutz Medical Campus Objectives Understand the role of PCSK9 inhibitors in the American Heart Association and the American College of Cardiology hyperlipidemia management guidelines Review the pertinent drug information and clinical benefits of the use of PCSK9 inhibitors in the treatment of hyperlipidemia. Describe the role of the pharmacist in patient education and counseling on PCSK9 inhibitors for the treatment of hyperlipidemia through motivational interviewing. CE LINK HERE: https://www.pharmacytimes.org/on-demand/pcsk9-inhibitors-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-with-hyperlipidemia-management  PTCE - Pharmacy Times Continuing Education  See omnystudio.com/listener for privacy information. [audioFile] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/83fd4242-3351-11ec-b33f-db405d357112/stripped_bcf211b66632cfa8d0f8e866798719ae.mp3 [downloadUrl] => https://traffic.megaphone.fm/CSN7133539274.mp3 [size] => 27649671 [duration] => 1728.1 [uid] => CSN7133539274 [originalUrl] => https://chrt.fm/track/9E721/traffic.omny.fm/d/clips/1eb5bacd-67ef-4d44-bf2a-a9f2000e0bb8/205ebaaa-1735-4516-9d9e-a9f8015d6a71/2a23fca7-41a8-47dc-b2dc-ac98013ed066/audio.mp3?utm_source=Podcast&in_playlist=84d2a465-54cf-41dd-b741-aa870121de98&t=1608613316 [bitrate] => 128 [samplerate] => 44100 [channelMode] => stereo [vbr] => [audioFileProcessing] => [podcastId] => 7f3056f0-3351-11ec-9023-5f47ace416a9 [preCount] => 0 [postCount] => 0 [insertionPoints] => Array ( ) [id3File] => https://megaphone-prod.s3.amazonaws.com/podcasts/7f3056f0-3351-11ec-9023-5f47ace416a9/episodes/83fd4242-3351-11ec-b33f-db405d357112/id3/b3ec800c2743ebde710264fef266c161.mp3 [id3FileProcessing] => [id3FileSize] => 60267 [parentId] => [guid] => 2a23fca7-41a8-47dc-b2dc-ac98013ed066 [pubdateTimezone] => [originalFilename] => [preOffset] => 0.0 [postOffset] => 0.0 [spotifyIdentifier] => [expectedAdhash] => [audioFileUpdatedAt] => 2021-10-22T18:02:57.882+02:00 [draft] => [externalId] => [cleanTitle] => PCSK9 Inhibitors | Pharmacy Connect Podcast [customFields] => [podcastTitle] => PTCE Pharmacy Connect | Pharmacy Times [networkId] => 350149ba-8137-11e8-b024-4351158a124b [podcastAuthor] => Pharmacy Podcast Network [podcastItunesCategories] => Array ( [0] => Business [1] => News [2] => Business News [3] => Science [4] => Health & Fitness [5] => Medicine ) [advertisingTags] => Array ( ) [mainFeed] => 1 [adFree] => [audioFileStatus] => success [status] => published )
  • Pharmacy Connect Podcast: PCSK9 Inhibitors Title: PCSK9 Inhibitors:Understanding the Pharmacist’s...
PTCE Pharmacy Connect | Pharmacy Times

PTCE Pharmacy Connect | Pharmacy Times

Pharmacy Times Continuing Education Free Continuing Education By Pharmacists For Pharmacists https://www.pharmacytimes.org/topic?t=Podcast